Form 4 for MDT Medtronic
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-29 · accession 0001613103-24-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-31 | 2024-07-29 | MDT | Martha Geoffrey | COB, CEO, Dir | A - Grant | $0.00 | +40.0K | 184.1K | +28% | $0 |
| DM | 2024-07-31 | 2024-07-29 | MDT | Martha Geoffrey | COB, CEO, Dir | A - Grant | $0.00 | +395.7K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-07-29 | A | A | 40,000 | $0.00 | 184,120 | D | — | — | (F1) The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. (F2) Includes 772 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-07-29 | A | A | 295,680 | $0.00 | 295,680 | D | $80.00 · — to 2034-07-29 | 295,680 Ordinary Shares | (F6) These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 3 | Derivative | Performance Share Unit | 2024-07-29 | A | A | 100,000 | $0.00 | 100,000 | D | — · — to — | 100,000 Performance Share Units | (F3) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F4) Vests on July 29, 2027. |